Universal flu vaccine the holy grail for researchers

05/19/2009 | NYTimes.com

The threat of a swine flu pandemic has prompted scientists and vaccine manufacturers to ramp up efforts to develop a universal influenza vaccine that can provide protection for years, if not a lifetime, against pandemic and seasonal strains. VaxInnate, Merck & Co. and Sanofi-Aventis unit Acambis are exploring the M2 protein that is found inside the flu virus, and other researchers are focusing on isolating the hemagglutinin protein outside the virus as a starting point in creating a universal vaccine.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT